Composition, form of production and packaging
Solution for the / m introduction 1 amp.
cattle hydrolyzate 1 ml
ampoules of dark glass (5) - packings, cellular outline (1) - packs of cardboard.
ampoules of dark glass (5) - contour plastic packaging (2) - cardboard packs.
ampoules of dark glass (5) - pallets (2) - cardboard packs.
ampoules of dark glass (10) - packs of cardboard.
ampoules (10) - packs of cardboard.
ampoules of dark glass (10) - packings, cellular outline (1) - packs of cardboard.
ampoules of dark glass (10) - packings, cellular outline (2) - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2010.
PHARMACHOLOGIC EFFECT
Cerebrolysate is a preparation of the brain tissue, contains amino acids and biologically active peptides that penetrate the blood-brain barrier and directly enter the nerve cells. Cerebrolysate improves metabolic processes in the brain cells, activates the synthesis of proteins in neurons, increases the resistance of brain tissue to intoxication, hypoxia, hypoglycemia; improves the state of regulatory mechanisms and bioelectrical activity of the brain, increases the reserve compensatory possibilities of cerebral hemodynamics. All this leads to a decrease in the severity of the neurological deficit.
INDICATIONS
- as part of the complex therapy of cerebrovascular insufficiency (dyscirculatory encephalopathy;
- ischemic stroke (acute phase and stage of rehabilitation);
- condition after hemorrhagic stroke;
- Traumatic brain injury (concussion, craniocerebral trauma, condition after surgical intervention on the brain);
- encephalopathy of different genesis;
- Myelopathy;
- Neuropathy;
- radiculopathy of various genesis (infectious, toxic, traumatic);
- cerebral palsy;
- reduced concentration in children.
DOSING MODE
Intramuscularly administered 1-5 ml daily or every other day. The course of treatment is 20 injections.
After a 3-6 month break, treatment with cerebrolysates can be repeated (after consulting a doctor).
In neuropediatric practice - intramuscularly, 1-2 ml (up to 1 ml per 10 kg body weight) for 10-15 days, with a repetition of the course 2-3 times a year.
SIDE EFFECT
Injections of the drug in some cases cause local soreness, irritation, flushing. Possible allergic reactions, increased blood pressure (with concomitant arterial hypertension).
CONTRAINDICATIONS
- severe renal dysfunction;
- status epilepticus;
- Pregnancy;
hypersensitivity.
With caution: the drug is prescribed during lactation.
PREGNANCY AND LACTATION
Contraindicated in pregnancy. With caution: the drug is prescribed during lactation.
APPLICATION FOR FUNCTIONS OF THE LIVER
Contraindicated in severe impairment of kidney function.
SPECIAL INSTRUCTIONS
With caution should prescribe the drug for allergic diathesis, epilepsy.
OVERDOSE
At present, no cases of drug overdose have been reported.
DRUG INTERACTION
Simultaneous use of cerebrolysate with antidepressants can cause an increase in their effect.
TERMS OF RELEASE FROM PHARMACY
On prescription.
TERMS AND CONDITIONS OF STORAGE
List B. Keep in a place protected from light and inaccessible to children, at a temperature not exceeding 20 ° С. Shelf life - 3 years.
